Dr. Marc Siegel: GLP-1 drugs could be used to slow biological aging
Varney & Company · FBN · Aired Mon, Oct 12 · 1m 43sAlready a subscriber?
Dr. Marc Siegel discusses findings from Eli Lilly and Novo Nordisk suggesting that GLP-1 receptor agonists can slow biological aging. He explains how these drugs reduce bodily inflammation and improve cellular metabolism, potentially leading to future use purely for longevity.